8:00
Update in Psoriasis (I)
Chairmen: Daciana Branisteanu, Magda Constantin
[8.00-8.30] Is another anti-TNF alpha needed in Psoriasis?
Supported by UCB Pharma
[8.30-8.45] The role of interleukin 17A inhibition in the complete management of psoriatic disease
Supported by Novartis
[8.45-9.15] Controversies regarding biological treatment in psoriasis
9:30
Update Psoriasis (II)
Expert meeting
Chairmen: Remus Orasan, Rodica Olteanu
[9.30-10.10] Pathogeny changing in psoriasis with Guselkumab
Supported by Janssen
[10.10-10.30] Resetting the horizons in psoriasis
Supported by Abbvie
[10.30-11.00] Expert meeting: Challenges in the management of the psoriasis patient in real life
11:30
Pharma symposia
Chairmen: Simona Ianosi, Carmen Curea
[11.30-11.45] Novartis
Real World Evidence with Secukinumab - Beyond randomised clinical trials
[11.45-12.00] Sanofi
Dupilumab – A new approach in atopic dermatitis
[12.00-12.15] Rilastil
Rilastil Acnestil – proper treatment for mild to moderate acne
[12.15-12.45] Genesis
Apremilast – mechanism of action
[12.45-13.05] Terapia
"23 is not just a number. Tildrakizumab is not just another inhibitor"
[13.05-13.20] Eli lillyIxekizumab: sustained effectiveness from head to toe
14:30
Modern methods of diagnosis and treatment in skin oncological pathology
Chairmen: Ana-Maria Forsea, Daniel Boda
[14.30-14.50] The main dermatoscopic aspects in skin tumors
[14.50-15.10] In vivo Reflective confocal microscopy - a useful diagnostic method in skin oncological pathology
[15.10-15.30] Optical coherence tomography (OCT) in dermatology - current events and perspectives
[15.30-15.50] The role of Mohs microinvasive surgery in dermato-oncological treatment
16:30
Update in skin tumors
Chairmen: Virgil Patrascu, Costin Caruntu
[16.30-16.50] Multiple nodular cutaneous metastasis as first clinical sign of signet ring cell gastric carcinoma - case report.
[16.50-17.10] Monitoring individuals at high risk for melanoma - tips for the dermatologist's clinical practice
[17.10-17.30] Skin carcinomas, prognostic factors
[17.30-17.50] Kaposi Sarcom – update
18:00
News in viral skin infections
Chairmen: Maria Rotaru, Ladislau Fekete
[18.00-18.20] Skin manifestations in SARS -COV 2 infection
[18.20-18.40] COVID-19 vaccination for special populations
[19.00-19.20] Cutaneous-mucosal manifestations in HIV-infected patients in the Oltenia region - 20 years of experience
[18.40-19.00] Clinical and therapeutic features in giant Buschke Lowenstain condylomatosis